% Define acronyms or abbreviations here

\unnsection{Abbreviations}%
% \addcontentsline{toc}{section}{Abbreviations} % Add to Table of Contents
% \markboth{Abbreviations}{} % > Mark this section for headers
\vspace{-\vfull}
\label{sec:Abbreviations}%
{%
    \footnotesize%
    \begin{spacing}{-.0}%
        \begin{acronym}%
            % == A
            \acro{APRIL}[APRIL]{A Proliferation-Inducing Ligand} %Tumor Necrosis Factor (Ligand) Superfamily, Member 13
            \acro{aMM}[aMM]{asymptomatic Multiple Myeloma}

            % == B
            \acro{BAFF}[BAFF]{B-cell Activating Factor}
            \acro{BM}[BM]{Bone Marrow}
            \acro{BMME}[BMME]{Bone Marrow Microenvironment}
            \acro{BMPC}[BMPC]{Bone Marrow Plasma Cell}
            \acro{BMSC}[BMSC]{Bone Marrow Stromal Cell}
            % \acroplural{BMSC}[BMSCs]{Bone Marrow Stromal Cells} % > Plural form

            % == C
            \acro{CAD}[CAD]{Cell Adhesion Dynamics}
            % \acro{CADD}[CADD]{Cell Attachment and Detachment Dynamics}
            \acro{CM}[CM]{hMSC-conditioned medium}
            \acro{CMina}[CM-INA6]{MSC-Conditioned-Medium-treated INA-6}
            \acro{CAM}[CAM]{Cell Adhesion Molecule}
            \acro{CLI}[CLI]{Command Line Interface}
            \acro{CXCL12}[CXCL12]{C-X-C Motif Chemokine Ligand 12}

            % == E
            \acro{ECM}[ECM]{Extracellular Matrix}
            \acro{EMT}[EMT]{Epithelial-Mesenchymal Transition}

            % == F
            \acro{FACS}[FACS]{Fluorescence-Activated Cell Sorting}

            % == G
            \acro{GUI}[GUI]{Graphical User Interface}

            % == H
            \acro{hMSC}[hMSC]{human Mesenchymal Stromal Cell}
            \acro{HSC}[HSC]{Hematopoietic Stem Cell}

            % == I
            \acro{IL-6}[IL-6]{Interleukin-6}
            \acro{IGF-1}[IGF-1]{Insulin-like Growth Factor 1}
            
            % == L
            \acro{LLM}[LLM]{Large Language Model}

            % == M
            \acro{MA}[MA]{MSC-adhering}
            \acro{MACS}[MACS]{Magnetic-Activated Cell Sorting}
            \acro{MSC}[MSC]{Mesenchymal Stromal Cell}
            \acro{MGUS}[MGUS]{Monoclonal Gammopathy of Undetermined Significance}
            \acro{MM}[MM]{Multiple Myeloma}
            \acro{MMR}[MMR]{Multiple Myeloma Relapse}
            \acro{MBD}[MBD]{Multiple Myleoma related Bone Disease}

            % == N
            \acro{NDMM}[NDMM]{Newly Diagnosed Multiple Myeloma}
            \acro{nMA}[nMA]{non-MSC-adhering}

            % == O
            \acro{OS}[OS]{Overall Survival}

            % == P
            \acro{PCL}[PCL]{Plasma Cell Leukemia}
            \acro{PFS}[PFS]{Progression-Free Survival}

            % == S
            \acro{SASP}[SASP]{Senescence-Associated Secretory Phenotype} % > in introduciton
            \acro{SDF-1}[SDF-1]{Stromal Cell-Derived Factor-1}
            \acro{sMM}[sMM]{smouldering Multiple Myeloma}
            \acro{SP}[SP]{Solitary Plasmacytoma}
            
            % == T
            % \acro{TNF-$\alpha$}[TNF-$\alpha$]{Tumor Necrosis Factor-$\alpha$}
            \acro{TRAIL}[TRAIL]{TNF-Related Apoptosis-Inducing Ligand}
            \acro{TNFSF13}[TNFSF13]{Tumor Necrosis Factor Superfamily, Member 13}
            
            % == V
            \acro{VCAM-1}[VCAM-1]{Vascular Cell Adhesion Molecule-1}
            \acro{VEGF}[VEGF]{Vascular Endothelial Growth Factor}
            \acro{VLA-4}[VLA-4]{Very Late Antigen-4}
            
            % == W
            \acro{WPSC}[WPSC]{Well Plate Sandwich Centrifugation}


        \end{acronym}
    \end{spacing}
}